Drug Profile
SPM VIII
Latest Information Update: 25 May 1995
Price :
$50
*
At a glance
- Originator Kirin Brewery
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 25 May 1995 Discontinued-Preclinical for Cancer in Japan (Unknown route)
- 07 Feb 1995 Preclinical development for Cancer in Japan (Unknown route)